Quarterlytics / Healthcare / Biotechnology / Seres Therapeutics, Inc.

Seres Therapeutics, Inc.

MCRB · NASDAQ Healthcare

Claim this profile

Ticker MCRB

Exchange NASDAQ

Sector Healthcare

Industry Biotechnology

Employees 103

Overview Coverage Annual Reports FAQ Peers Earnings Calls Financials News Management

Company Profile

Seres Therapeutics’ microbiome pivot: can SER-155 outrun the cash clock?

On Seres Therapeutics’ Q3 2025 earnings call, Co-CEO and CFO Marella Thorell stressed that the company’s $8.2 million profit was entirely the product of a $27.2…

MCRB Jun 18, 2026